BGMS vs GRWG vs HYFM vs LWAY

For growth investors, Lifeway Foods, Inc.

(LWAY) is the stronger pick with 13. 7% revenue growth year-over-year, versus -89. 8% for Bio Green Med Solution, Inc. (BGMS). Lifeway Foods, Inc. (LWAY) offers the better valuation at 28. 5x trailing P/E (22. 6x forward), making it the more compelling value choice. Analysts rate Lifeway Foods, Inc. (LWAY) a "Buy" — based on 6 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

Over the past 5 years, Lifeway Foods, Inc.

(LWAY) delivered a total return of +410. 3%, compared to -99. 8% for Hydrofarm Holdings Group, Inc. (HYFM). Over 10 years, the gap is even starker: LWAY returned +166. 7% versus HYFM's -99. 8%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Lifeway Foods, Inc.

(LWAY) is the lower-risk stock at 0. 73β versus Bio Green Med Solution, Inc. 's 1. 88β — meaning BGMS is approximately 158% more volatile than LWAY relative to the S&P 500. On balance sheet safety, Lifeway Foods, Inc. (LWAY) carries a lower debt/equity ratio of 0% versus 76% for Hydrofarm Holdings Group, Inc. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Lifeway Foods, Inc.

(LWAY) is pulling ahead at 13. 7% versus -89. 8% for Bio Green Med Solution, Inc. (BGMS). On earnings-per-share growth, the picture is similar: Bio Green Med Solution, Inc. grew EPS 92. 2% year-over-year, compared to -1. 9% for Hydrofarm Holdings Group, Inc.. Over a 3-year CAGR, LWAY leads at 14. 5% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Lifeway Foods, Inc.

(LWAY) is the more profitable company, earning 6. 5% net margin versus -260. 7% for Bio Green Med Solution, Inc. — meaning it keeps 6. 5% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: LWAY leads at 7. 6% versus -279. 2% for BGMS. At the gross margin level — before operating expenses — BGMS leads at 100. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

For long-horizon retirement investors, Lifeway Foods, Inc.

(LWAY) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 73), +166. 7% 10Y return). Bio Green Med Solution, Inc. (BGMS) carries a higher beta of 1. 88 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (LWAY: +166. 7%, BGMS: -84. 4%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (BGMS (Healthcare) and GRWG (Consumer Cyclical) and HYFM (Industrials) and LWAY (Consumer Defensive)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.